CinCor
CINCCinCor Pharma Price (CINC)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
35,419,099
(50.7602)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
CinCor Pharma, Inc.Currency: USD
| YEAR | 2019 | 2020 | 2021 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
0.00
+0% |
0.00
+0% |
0.00
+0% |
||||||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
0.00
+0% |
0.00
+0% |
0.00
+0% |
||||||||||||||||
| Gross Profit Ratio | (0.00%) | (0.00%) | (0.00%) | ||||||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 3,926,221.00 | 17,952,208.00 | 21,514,135.00 | ||||||||||||||||
| General and Administrative | 1,210,595.00 | 3,173,237.00 | 20,996,271.00 | ||||||||||||||||
| Selling, General & Admin... | 1,210,595.00 | 3,173,237.00 | 20,996,271.00 | ||||||||||||||||
| Selling & Marketing Exp... | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Depreciation and Amortiz... | 171,860.00 | 1,209,828.00 | 7,880,309.00 | ||||||||||||||||
| Other Expenses | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Total Operating Expenses | 5,136,816.00 | 21,125,445.00 | 42,510,406.00 | ||||||||||||||||
| Cost and Exponses | 5,136,816.00 | 21,125,445.00 | 42,510,406.00 | ||||||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-5,136,816.00
+0% |
-21,125,445.00
+311% |
-42,510,406.00
+101% |
||||||||||||||||
| Operating Income Ratio | (0.00%) | (0.00%) | (0.00%) | ||||||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 101,706.00 | 36,728.00 | 21,641.00 | ||||||||||||||||
| Interest Expenses | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Total Other Income/Exp... | 101,706.00 | -1,173,100.00 | -7,858,668.00 | ||||||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -5,136,816.00 | -19,915,617.00 | -34,630,097.00 | ||||||||||||||||
| EBITDA ratio | (0.00%) | (0.00%) | (0.00%) | ||||||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -5,035,110.00 | -22,298,545.00 | -50,369,074.00 | ||||||||||||||||
| Income Before Tax Ratio | (0.00%) | (0.00%) | (0.00%) | ||||||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | -101,706.00 | -36,728.00 | -21,641.00 | ||||||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | -4,933,404.00
+0% |
-22,261,817.00
+351% |
-50,347,433.00
+126% |
||||||||||||||||
| Net Income Ratio | (0.00%) | (0.00%) | (0.00%) | ||||||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | -0.21 | -0.95 | -1.42 | ||||||||||||||||
| Diluted EPS | -0.21 | -0.95 | -1.42 | ||||||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 23,493,662.00 | 23,493,662.00 | 35,419,099.00 | ||||||||||||||||
| Diluted Share Outstanding | 23,493,662.00 | 23,493,662.00 | 35,419,099.00 | ||||||||||||||||